Trevi Therapeutics Inc (TRVI) - Price Chart

TRVI (Trevi Corp) - company brandmark

The Trevi Therapeutics (TRVI) market valuation chart on the GURU.Markets platform reflects the price action of an asset focused on chronic cough therapy and the creation of a specialized environment for treating critically ill patients. The business strategy relies on expanding its portfolio of treatments for pruritus and neurological pathologies to mitigate risks. The current metric stands at 13.68, while the development of Haduvio requires significant expenditures prior to FDA verification.

Trevi Corp - TRVI Price Chart (period 07/04/2022 - 11/16/2026)

Trevi Pharma (TRVI) - metric breakdowns and financial figures

- current price and projected stock value:
Analysis of all company metrics:trevitherapeutics.com TRVI
Signature product of Trevi Therapeutics Inc

An investor assesses business capitalization through the market value of their stake. This indicator captures the daily balance of supply and demand, determining the current value of a single asset. For Trevi Therapeutics (TRVI), the price reflects market expectations regarding the commercial success of the drug Haduvio in the treatment of itch and cough. Fundamentally, this metric measures capital's confidence in the uniqueness of the development. By analyzing market price fluctuations, one can identify asset accumulation phases.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price SUPN|Price Chart Catalyst Pharmaceuticals|Share Price DNLI (Denali Therapeutics Inc)|Stock Price HRMY|BHVN - Market Price|amylyx.com - Stock Quotes|Stock Price Praxis Precision Medicines Inc PRAX|AVXL - Price Chart|Price Performance Chart CBLL (CeriBell EEG)|Prothena Corporation (PRTA) - Price Chart|Market Price Alector Inc. (ALEC)|ANNX (annexonbio.com) - Stock Price|Market Price omeros.com OMER|Stock Price NGNE|Stock Quotes AC Immune ACIU|Voyager Therapeutics Inc - Stock Quotes|Stock Price neumoratx.com NMRA|SCLX - Price Chart|Market Price Tevogen Bio|ACOG: Stock Price|CGTX - Market Chart|Price Chart Inhibikase Pharma|Price Chart SAVA|Stock Price ASRT|COYA (Coya Therapeutics) - Price Performance Chart|Price Chart vistagen.com VTGN|Ovid Therapeutics Inc. (OVID) - Market Price|Acumen Pharmaceuticals - Stock Price|Price Performance Chart CRVO (CervoMed Inc.)|ATHE (alteritytherapeutics.com) - Stock Quotes|CLNN - Market Chart|Stock Quotes PEPG|Stock Price jupiterneurosciences.com|Price Chart Relmada Therapeutics (RLMD)|ANVS (Annovis Bio, Inc.) - Price Performance Chart|Stock Price GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Market Price|Klotho Neurosciences - Stock Price|Market Price NeuroSense Therapeutics Ltd.|RVPH: Stock Price|MetaVia, Inc. (MTVA) - Stock Price|Stock Quotes NRXS|Helius Medical (HSDT) - Market Chart|Price Chart passagebio.com (PASG)|NEUP - Market Price|Price Chart Minerva Neurosciences, Inc. NERV|Market Chart Athira Pharma, Inc. (ATHA)|addextherapeutics.com - Stock Price|Market Chart alzamend.com ALZN|CYCN: Stock Price|PTIX: Price|Price Chart Pasithea Therapeutics Corp.|Stock Price cortigent.com|Stock Quotes ATXI (Avenue Therapeutics, Inc)|Stock Price Brainstorm Cell Therapeutics Inc. (BCLI)|Stock Price CARA (Cara Therapeutics Inc)|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel